Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 2/20 | 0.32 |
| ▸ | EEF2K | O00418 | 2/20 | 0.31 |
| ▸ | EEF2 | P13639 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | PLK4 | O00444 | 1/20 | 0.31 |
| ▸ | JAK2 | O60674 | 1/20 | 0.31 |
| ▸ | EGFR | P00533 | 1/20 | 0.31 |
| ▸ | TYK2 | P29597 | 1/20 | 0.31 |
| ▸ | FLT3 | P36888 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | ITK | Q08881 | 1/20 | 0.31 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2990537 | 0.82 | EEF2K (0.36) | ACHEEEF2KEEF2MEN1PLK4 | |
| SCHEMBL15670994 | 0.82 | KCNH2 (0.33) | ACHEEEF2KEEF2MEN1PLK4 | |
| Trifluoromethanesulfonic Acid SCHEMBL707414 | 0.81 | KCNH2 (0.43) | ACHEEEF2KEEF2MEN1PLK4 | |
| SCHEMBL5488936 | 0.80 | MEN1 (0.46) | MEN1KMT2A | |
| SCHEMBL2837397 | 0.80 | CA1 (0.38) | ACHEEEF2KEEF2MEN1PLK4 | |
| Sulfuric Acid SCHEMBL3006216 | 0.79 | KMT2A (0.40) | ACHEEEF2KEEF2MEN1PLK4 | |
| SCHEMBL526257 | 0.79 | RECQL (0.51) | ACHEEEF2KEEF2MEN1PLK4 | |
| SCHEMBL3000997 | 0.78 | KMT2A (0.40) | ACHEEEF2KEEF2MEN1PLK4 | |
| SCHEMBL23004253 | 0.78 | MEN1 (0.42) | ACHEEEF2KEEF2MEN1PLK4 | |
| Sulfuric Acid SCHEMBL4247480 | 0.77 | CA1 (0.41) | ACHEEEF2KEEF2MEN1PLK4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070219379-A1 | Ionic Liquid and Process for Producing the Same | KANEKA CORPORATION (JP) | 2007-09-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070219379-A1 | Ionic Liquid and Process for Producing the Same | HCN4, HCN2, HCN3 | ACHE 1466/4885EEF2K 1816/4885EEF2 3046/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.